Key result
FDG PET-CT was utilized for the initial staging and postchemotherapy response assessment of a rare case of primary pleural synovial cell sarcoma.
Why the study?
Does FDG PET-CT improve initial staging and response assessment in primary pleural synovial sarcoma?
Case Report (n=1)
Does FDG PET-CT improve initial staging and response assessment in primary pleural synovial sarcoma?
FDG PET-CT may be useful for staging and assessing treatment response in rare cases of primary pleural synovial sarcoma.
Hypothesis-generating for FDG PET-CT staging and response assessment in primary pleural synovial sarcoma; prospective validation required before adoption.
Primary pleural sarcomas constitute <1% of all primary lung cancers. Synovial sarcomas of the pleura are extremely rare. They may be mistaken for malignant mesothelioma or other spindle cell tumors, but the confirmation is by histology and immunohistochemistry. Synovial sarcomas are aggressive with a high incidence of recurrence. In this case report, we present the 18-fluoride-fluoro deoxyglucose (FDG) positron emission tomography-computerized tomography (PET-CT) findings of patient with primary pleural synovial cell sarcoma. The pretreatment and postchemotherapy FDG PET-CT scans are presented. The role of FDG PET-CT in initial staging and response assessment in this interesting case of pleural synovial sarcoma is presented.
No takes yet. Share an insight, caveat, or question.
Harisankar et al. (2014) conducted a case report in Primary pleural synovial sarcoma (n=1). 18-fluoride-fluoro deoxyglucose (FDG) positron emission tomography-computerized tomography (PET-CT) was evaluated on Initial staging and response assessment. FDG PET-CT was utilized for the initial staging and postchemotherapy response assessment of a rare case of primary pleural synovial cell sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: